HighTower Advisors’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $457K | Buy |
|
|||||
|
2025
Q1 | $484K | Buy |
|
|||||
|
2024
Q4 | $652K | Sell |
|
|||||
|
2024
Q3 | $352K | Sell |
|
|||||
|
2024
Q2 | $344K | Buy |
|
|||||
|
2024
Q1 | $386K | Sell |
|
|||||
|
2023
Q4 | $361K | Sell |
|
|||||
|
2023
Q3 | $2.53M | Sell |
|
|||||
|
2023
Q2 | $3.94M | Buy |
|
|||||
|
2023
Q1 | $1.56M | Sell |
|
|||||
|
2022
Q4 | $3.03M | Buy |
|
|||||
|
2022
Q3 | $919K | Sell |
|
|||||
|
2022
Q2 | $840K | Sell |
|
|||||
|
2022
Q1 | $1.09M | Sell |
|
|||||
|
2021
Q4 | $987K | Sell |
|
|||||
|
2021
Q3 | $1.23M | Buy |
|
|||||
|
2021
Q2 | $1.13M | Hold |
|
|||||
|
2021
Q1 | $1.62M | Buy |
|
|||||
|
2020
Q4 | $373K | Sell |
|
|||||
|
2020
Q3 | $153K | Sell |
|
|||||
|
2020
Q2 | $113K | Hold |
|
|||||
|
2020
Q1 | $72K | Buy |
|
|||||
|
2019
Q4 | $113K | Hold |
|
|||||
|
2019
Q3 | $65K | Buy |
|
|||||
|
2019
Q2 | $130K | Sell |
|
|||||
|
2019
Q1 | $355K | Sell |
|
|||||
|
2018
Q4 | $512K | Sell |
|
|||||
|
2018
Q3 | $1.09M | Buy |
|
|||||
|
2018
Q2 | $1.31M | Sell |
|
|||||
|
2018
Q1 | $1.36M | Sell |
|
|||||
|
2017
Q4 | $3.2M | Sell |
|
|||||
|
2017
Q3 | $3.72M | Buy |
|
|||||
|
2017
Q2 | $3.9M | Buy |
|
|||||
|
2017
Q1 | $4.29M | Buy |
|
|||||
|
2016
Q4 | $1.69M | Buy |
|
|||||
|
2016
Q3 | $1.33M | Hold |
|
|||||
|
2016
Q2 | $959K | Buy |
|